Treatment of Childhood Social Phobia
- Conditions
- Social Phobia
- Interventions
- Registration Number
- NCT00043537
- Lead Sponsor
- University of Central Florida
- Brief Summary
This 4-year study will compare the long-term effectiveness of behavioral treatment, fluoxetine (Prozac®), and placebo for treatment of social phobia in children and adolescents.
- Detailed Description
Social phobia affects 3-5 percent of children, and prevalence rises with age. Youth with social phobia fear many activities that are part of everyday life and suffer from problems such as headaches or stomachaches, panic, avoidance, general anxiety, depression, loneliness, and a very restricted range of social relationships. Recent findings indicate a new psychosocial treatment called Social Effectiveness Therapy for Children (SET-C) is effective in treating children ages 8-11, resulting in reduced emotional distress and improved social functioning. Treatment effects have been maintained for up to 6 months. This study will examine SET-C in children ages 8-15. Because available data suggest that the drug fluoxetine is a promising treatment, SET-C will be compared to fluoxetine in this trial. Durability of treatment will be monitored over a 1-year follow-up period.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 139
- Diagnosis of social phobia
- Pervasive developmental disorders (PDD)
- Schizophrenia
- Major Depression
- IQ of less than 80
- Medical conditions contraindicating use of fluoxetine
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Social Effectiveness Therapy for Children Social Effectiveness Therapy for Children (SET-C) Social Effectiveness Therapy for Children includes social skills training, peer generalization experiences and exposure therapy Pill placebo Pill Placebo Capsules identical to fluoxetine given in "10 mg." doses up to 40 mg. Fluoxetine Fluoxetine Fluoxetine given in 10mg doses, up to 40 mg as tolerated
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Maryland Center for Anxiety Disorders
🇺🇸University of Maryland, College Park, Maryland, United States